Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-02

FDA Approved: RESTART — Original Application (Winx Health Inc.)

View source ↗

Summary

FDA approves Winx Health Inc.'s original application for RESTART (levonorgestrel), bringing a generic contraceptive to market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RESTART (LEVONORGESTREL)

Snippet

ORIG AP for RESTART (LEVONORGESTREL)